Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Immunology (Orlando, Fla.)|May 16, 2009
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 yearsKevan C Herold, Stephen Gitelman, Carla Greenbaum, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2006
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitisThomas B Casale, William W Busse, Joel N Kline, et al.
Diabetes|August 29, 2006
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled studyVicki Seyfert-Margolis, Trang D Gisler, Adam L Asare, et al.
Clinical Pharmacology and Therapeutics|September 22, 2021
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare EcosystemHarry P Selker, Theodora Cohen, Ralph B D'Agostino, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitisJohn H Stone, Peter A Merkel, Robert Spiera, et al.
The New England Journal of Medicine|September 29, 2006
International trial of the Edmonton protocol for islet transplantationA M James Shapiro, Camillo Ricordi, Bernhard J Hering, et al.
The Journal of Clinical Investigation|May 27, 2010
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humansPervinder Sagoo, Esperanza Perucha, Birgit Sawitzki, et al.
Nature Communications|January 3, 2024
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC studyAl Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Pageof 2